Skip to main content

Diabetes Mellitus: Insulin Administration Devices!

 INSULIN ADMINISTRATION DEVICES

INSULIN PUMP THERAPY:

"Insulin pump therapy consists of a programmable infusion device that allows for basal infusion 24hrs daily as well as bolus administration before meals and snacks".

  • Regular or rapid acting insulin is delivered from a reservoir either by infusion set tubing or through a small canula.
  • Most infusion pumps are set in the abdomen, arm or other infusion sites by a small needle. 
  • Most patients prefer insertion in the abdominal tissue because this site provides optimal insulin absorption. 
  • Infusion sets should be changed every 2-3 days to reduce the possibility of infection.


Determination of Insulin Units:

  • Patients use carbohydrate-to-insulin ratio to determine how many units of insulin are required. 
  • More specifically, an individual's ratio is calculated to determine how many units of the specific insulin being used in the pump "covers" for a certain amount of carbohydrates to be ingested at a particular level.

1. The 450 Rule (for Regular Insulin) or the 500 rule(for Rapid acting Insulin) are the most commonly used.

The 500 Rule:

  • To calculate the ratio using 500 rules; the patient would divide 500 by his or her total daily dose of insulin.
  • Eg; If a patient were using 25 units of insulin daily, his/her carbohydrate-to-insulin ratio could be 500:25 or 20:1.

This ratio theoretically means that 1 unit of rapid acting insulin should cover 20g of carbohydrates.

  • If the blood glucose levels are below or above the desired blood glucose target, the amount of insulin can be adjusted.
  • Once this ratio is determined, patients can eat more or fewer carbohydrates at a given meal and adjust the bolus dose accordingly.
Correction Doses:

In addition to meantime boluses, Correction doses based on premeal readings are also used.

  • The amount of additional insulin for the correction is based on either the 1500 rule for regular insulin or the 1800 rule for rapid-acting insulin.
  • For eg; if using the rapid acting insulin, divide 1800 by the patients total daily insulin dose. The resulting value will represent the reduction in glucose (mg/dL) produced by one unit of Insulin.

The 1800 rule:

  • Using the 1800 rule; we find that 1800 is divided by 60 which gives 30. Thus, 1 unit of rapid acting insulin would be added for every 30mg/dL the patients' glucose is above the premeal glucose levels as a correction factor.

The correction dose would be given in addition to the bolus dose needed based on the patient's carbohydrate-to-insulin ratio and the amount of carbohydrates present in the meal he/she is about to consume.


USES OF INSULIN PUMP THERAPY

Insulin pump therapy may be used to

  1. lower blood glucose level in any level of DM
  2. Patients of T1DM are most likely candidates to use these devices.
  3. Use of an insulin pump may improve blood glucose control, reduce wide fluctuations in blood glucose levels, and allow individuals to have more flexibility in timing and content of meals and exercise schedules.

DRAWBACKS

  • Insulin pump therapy is not for everyone, and the complexity associated with its use, cost, increased need for blood glucose monitoring and the psychological factors may prevent individuals from using this technology optimally.


Labels:

Comments

Post a Comment

Popular posts from this blog

General Mechanism of Actions of INSULIN.

GENERAL MECHANISM OF ACTION OF INSULIN AND RELATE HORMONES The body's main fuel is Glucose. Glucose is stored in the liver and muscles as Glycogen.  Excess glucose is stored in the adipose tissues which yield fatty acids via lipolysis. In the fasting state, free fatty acids supply much of the energy needs of the body except for the CNS which requires Glucose to function normally. Proteins can also be converted to glucose via gluconeogenesis. RELEASE OF INSULIN AND GLUCAGON Insulin and Glucagon are produced in the pancreas by the Islets of Langerhans . Beta cells   make up 70%-90% of the Islets and produce Insulin and Amylin while the a-cells   produce glucagon. The main function of insulin is to decrease blood glucose levels. Glucagon, along with other counter-regulatory hormones such as growth factor, cortisol, and Epinephrine, increases Blood glucose levels.  The opposing actions of Glucagon and Insulin along with other counter-regulatory hormones maintain a norma...
Post a Comment
Read more

Diabetes Mellitus: Its Goals Of Therapy!

  GOAL OF THERPY The goals of treatment of DM includes; Reducing, controlling and managing long-term microvascular, macrovascular and neuropaathic complications. Preserving beta cell function. Preventing acute complications from increased Blood glucosel level. Minimizing hypoglycemic episodes. Maintaining patient quality of life. --Two landmark trials, THE DIABETES CONTROL AND COMPLICATION TRIAL (DCCT) and THE UNITED KINGDOM PROSPECTIVE DIABETES STUDY(UKPDS), showed that lowering blood glucose levels decreased the risk of developing chronic complications. --A near normal blood glucose level can be achieved with appropriate patient education , lifestyle modification and medications . --Proper care of DM requires goal setting and assessment for glycemic control , self-monitoring of blood glucose (SMBG) monitoring of blood glucose pressure , and lipid levels , regular monitoring for the development of complications , dietary and exercise lifestyle modifications and proper medicatio...
Post a Comment
Read more

Diabetes Mellitus: Clinical Presentation and Diagnosis!

 CLINICAL PRESENTATION AND DIAGNOSIS OF DM 2. SCREENING American Diabetes Association (ADA) recommends routine screening for T2 DM every 3 years in all adults starting at 45 years of age. Testing of T2 DM should be considered in any adult, regardless of their age, who have a BMI greater than or equal to 25kg/m2. The ADA does not currently recommend widespread screening for T1 DM because of the relatively low incidence in the general population, although measurement of Islet antibodies may be appropriate for high-risk individuals. 3.GESTATIONAL DIABETES: "Gestational diabetes is the glucose intolerance in women during pregnancy". All pregnant women who have risk factors for T2 DM should be screened for undiagnosed T2 DM at their first prenatal visit using standard diagnostic criteria.  Any women found to have diabetes in the early point at pregnancy is considered to have T2 DM or GDM. All other pregnant women, not currently known to have DM should be screened for GDM with a 75...
Post a Comment
Read more